<div class="elementor-post__thumbnail elementor-fit-height imagem_injetada" style="margin-bottom:7px; display:none;"><img width="300" height="168" src="https://www.femama.org.br/site_old/_files/noticia/3969/610005587f189.jpg" class="attachment-medium size-medium" alt=""></div><div class="elementor-post__thumbnail elementor-fit-height imagem_injetada" style="margin-bottom:7px; display:none;"><img width="300" height="168" src="https://www.femama.org.br/site_old/_files/noticia/3969/610005587f189.jpg" class="attachment-medium size-medium" alt=""></div>{"id":19712,"date":"2021-07-27T00:00:00","date_gmt":"2021-07-27T03:00:00","guid":{"rendered":"https:\/\/femama.org.br\/site_novo\/noticias-recentes\/bolsonaro-veta-projeto-que-facilitaria-acesso-a-remedios-orais-contra-cancer-informa-planalto\/"},"modified":"2021-07-27T00:00:00","modified_gmt":"2021-07-27T03:00:00","slug":"bolsonaro-veta-projeto-que-facilitaria-acesso-a-remedios-orais-contra-cancer-informa-planalto","status":"publish","type":"post","link":"https:\/\/femama.org.br\/site\/noticias-recentes\/bolsonaro-veta-projeto-que-facilitaria-acesso-a-remedios-orais-contra-cancer-informa-planalto\/","title":{"rendered":"Bolsonaro veta projeto que facilitaria acesso a rem\u00e9dios orais contra c\u00e2ncer, informa Planalto"},"content":{"rendered":"<div data-block-type=\"unstyled\" data-block-weight=\"31\" data-block-id=\"1\">\n<p style=\"text-align: justify;\" data-track-category=\"Link no Texto\" data-track-links=\"\">A Secretaria-Geral da Presid&ecirc;ncia informou nesta segunda-feira (26) que o presidente&nbsp;Jair Bolsonaro&nbsp;vetou um projeto que&nbsp;facilitaria o acesso a rem&eacute;dios orais contra c&acirc;ncer&nbsp;por meio dos planos de sa&uacute;de. A proposta foi&nbsp;aprovada pelo Congresso Nacional no in&iacute;cio deste m&ecirc;s&nbsp;e visava reduzir as exig&ecirc;ncias para que os planos de sa&uacute;de fossem obrigados a custear tratamentos orais contra o c&acirc;ncer. Vetos presidenciais a projetos ou a trechos de projetos aprovados pelo Poder Legislativo precisam ser analisados pelos parlamentares, que&nbsp;podem mant&ecirc;-los ou derrub&aacute;-los.<\/p>\n<\/div>\n<div>\n<div data-block-type=\"unstyled\" data-block-weight=\"23\" data-block-id=\"4\">\n<div style=\"text-align: justify;\" data-block-type=\"unstyled\" data-block-weight=\"35\" data-block-id=\"7\">\n<p data-track-category=\"Link no Texto\" data-track-links=\"\">Em julho, a&nbsp;C&acirc;mara dos Deputados&nbsp;aprovou o projeto&nbsp;por 388 votos a 10. No Senado, a proposta do senador Reguffe (Podemos-DF) foi aprovada em 2020 de forma un&acirc;nime pelos 74 senadores presentes &agrave; sess&atilde;o. Segundo o governo, o texto do projeto poderia comprometer o mercado dos planos de sa&uacute;de por n&atilde;o observar aspectos como &#8220;previsibilidade&#8221;, &#8220;transpar&ecirc;ncia&#8221; e &#8220;seguran&ccedil;a jur&iacute;dica&#8221;.<\/p>\n<\/div>\n<div style=\"text-align: justify;\" data-block-type=\"unstyled\" data-block-weight=\"33\" data-block-id=\"9\">\n<p data-track-category=\"Link no Texto\" data-track-links=\"\">Ainda de acordo com o governo, o texto poderia &#8220;criar discrep&acirc;ncias no tratamento das tecnologias e, consequentemente, no acesso dos bene\ufb01ci&aacute;rios ao tratamento de que necessitam, privilegiando os pacientes acometidos por doen&ccedil;as oncol&oacute;gicas&#8221;.<\/p>\n<\/div>\n<div style=\"text-align: justify;\" data-block-type=\"raw\" data-block-weight=\"2\" data-block-id=\"10\">\n<div>\n<h2>O prejeto<\/h2>\n<\/div>\n<\/div>\n<div style=\"text-align: justify;\" data-block-type=\"unstyled\" data-block-weight=\"25\" data-block-id=\"11\">\n<p data-track-category=\"Link no Texto\" data-track-links=\"\">A regra atualmente em vigor prev&ecirc; que, para o tratamento domiciliar, o medicamento s&oacute; deve ser pago pelo plano de sa&uacute;de se for aprovado:<\/p>\n<\/div>\n<div style=\"text-align: justify;\" data-block-type=\"raw\" data-block-weight=\"30\" data-block-id=\"12\">\n<ul>\n<li>pela Ag&ecirc;ncia Nacional de Vigil&acirc;ncia Sanit&aacute;ria (Anvisa), que regula todas as medica&ccedil;&otilde;es em uso no pa&iacute;s;<\/li>\n<li>pela Ag&ecirc;ncia Nacional de Sa&uacute;de Suplementar (ANS), que regula os planos e seguros m&eacute;dicos.<\/li>\n<\/ul>\n<\/div>\n<div style=\"text-align: justify;\" data-block-type=\"unstyled\" data-block-weight=\"33\" data-block-id=\"13\">\n<p data-track-category=\"Link no Texto\" data-track-links=\"\">A ANS, por&eacute;m, demora mais de um ano para rever a lista dos rem&eacute;dios que os planos s&atilde;o obrigados a pagar &ndash; o que, segundo defensores do projeto, &eacute; um tempo muito longo.<\/p>\n<\/div>\n<div style=\"text-align: justify;\" data-block-type=\"unstyled\" data-block-weight=\"33\" data-block-id=\"15\">\n<p data-track-category=\"Link no Texto\" data-track-links=\"\">Se Bolsonaro sancionasse o texto, ficaria retirada a exig&ecirc;ncia da inclus&atilde;o do medicamento nos protocolos da ANS, e o plano de sa&uacute;de teria que fornecer o tratamento a partir do registro da Anvisa.<\/p>\n<\/div>\n<div style=\"text-align: justify;\" data-block-type=\"raw\" data-block-weight=\"1\" data-block-id=\"16\">\n<div>\n<h2>Justificativa<\/h2>\n<\/div>\n<\/div>\n<div style=\"text-align: justify;\" data-block-type=\"unstyled\" data-block-weight=\"37\" data-block-id=\"17\">\n<p data-track-category=\"Link no Texto\" data-track-links=\"\">Na Justificativa para o veto, o governo afirmou que o texto poderia &#8220;criar discrep&acirc;ncias no tratamento das tecnologias e, consequentemente, no acesso dos bene\ufb01ci&aacute;rios ao tratamento de que necessitam, privilegiando os pacientes acometidos por doen&ccedil;as oncol&oacute;gicas&#8221;.<\/p>\n<\/div>\n<div style=\"text-align: justify;\" data-block-type=\"unstyled\" data-block-weight=\"48\" data-block-id=\"18\">\n<p data-track-category=\"Link no Texto\" data-track-links=\"\">O governo tamb&eacute;m argumentou a obriga&ccedil;&atilde;o de fornecimento dos rem&eacute;dios pelos planos de sa&uacute;de em um prazo de 48 horas ap&oacute;s a prescri&ccedil;&atilde;o criaria um acesso privilegiado a novas tecnologias de tratamento para os benefici&aacute;rios em raz&atilde;o da dispensa da an&aacute;lise da Ag&ecirc;ncia Nacional de Sa&uacute;de Suplementar.<\/p>\n<\/div>\n<div style=\"text-align: justify;\" data-block-type=\"unstyled\" data-block-weight=\"43\" data-block-id=\"19\">\n<p data-track-category=\"Link no Texto\" data-track-links=\"\">Segundo o governo, um outro efeito do projeto seria &#8220;o inevit&aacute;vel repasse desses custos adicionais aos consumidores, de modo a encarecer, ainda mais, os planos de sa&uacute;de, al&eacute;m de trazer riscos &agrave; manuten&ccedil;&atilde;o da cobertura privada aos atuais benefici&aacute;rios, particularmente os mais pobres&#8221;.<\/p>\n<\/div>\n<div style=\"text-align: justify;\" data-block-type=\"raw\" data-block-weight=\"3\" data-block-id=\"20\">\n<div>\n<h2>Lista da ANS<\/h2>\n<\/div>\n<\/div>\n<div style=\"text-align: justify;\" data-block-type=\"unstyled\" data-block-weight=\"25\" data-block-id=\"21\">\n<p data-track-category=\"Link no Texto\" data-track-links=\"\">Respons&aacute;vel pelas diretrizes gerais dos planos de sa&uacute;de, a ANS define uma lista de consultas, exames e tratamentos que os seguros s&atilde;o obrigados a pagar.<\/p>\n<\/div>\n<div style=\"text-align: justify;\" data-block-type=\"unstyled\" data-block-weight=\"35\" data-block-id=\"22\">\n<p data-track-category=\"Link no Texto\" data-track-links=\"\">A lista de procedimentos varia com o tipo de plano contratado &ndash; h&aacute; ap&oacute;lices que n&atilde;o incluem interna&ccedil;&atilde;o e cirurgias, por exemplo. Essa rela&ccedil;&atilde;o &eacute; atualizada periodicamente, quando novos medicamentos e tratamentos tamb&eacute;m s&atilde;o avaliados.<\/p>\n<\/div>\n<div style=\"text-align: justify;\" data-block-type=\"unstyled\" data-block-weight=\"24\" data-block-id=\"23\">\n<p data-track-category=\"Link no Texto\" data-track-links=\"\">O texto aprovado deixa claro que os planos precisam cobrir os medicamentos orais contra o c&acirc;ncer, seja no tratamento ambulatorial ou na interna&ccedil;&atilde;o hospitalar.<\/p>\n<\/div>\n<div style=\"text-align: justify;\" data-block-type=\"unstyled\" data-block-weight=\"19\" data-block-id=\"24\">\n<p data-track-category=\"Link no Texto\" data-track-links=\"\">No caso da interna&ccedil;&atilde;o, o projeto ainda obriga os planos a oferecerem ao cliente dois outros tipos de tratamento:<\/p>\n<\/div>\n<div data-block-type=\"raw\" data-block-weight=\"36\" data-block-id=\"25\">\n<ul style=\"text-align: justify;\">\n<li>a radioterapia, que se baseia em radia&ccedil;&atilde;o para reduzir o tumor ou impedir o crescimento dele;<\/li>\n<li>a hemoterapia, procedimento em que o pr&oacute;prio sangue do paciente &eacute; retirado e reinjetado na tentativa de melhorar sua imunidade;<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong><a href=\"https:\/\/g1.globo.com\/politica\/noticia\/2021\/07\/26\/bolsonaro-veta-projeto-que-facilitava-acesso-a-remedios-orais-contra-cancer-informa-planalto.ghtml?utm_source=push&amp;utm_medium=app&amp;utm_campaign=pushg1\" target=\"_blank\" rel=\"noopener\">Fonte: G1<\/a><\/strong><\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<h2>Projeto visava reduzir exig&ecirc;ncias relacionadas aos planos de sa&uacute;de. Segundo governo, texto poderia comprometer o mercado por n&atilde;o observar aspectos como &#8216;previsibilidade&#8217;.<\/h2>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[20,13],"tags":[],"class_list":["post-19712","post","type-post","status-publish","format-standard","hentry","category-direito-dos-pacientes","category-noticias-recentes"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Bolsonaro veta projeto que facilitaria acesso a rem\u00e9dios orais contra c\u00e2ncer, informa Planalto | FEMAMA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/femama.org.br\/site\/noticias-recentes\/bolsonaro-veta-projeto-que-facilitaria-acesso-a-remedios-orais-contra-cancer-informa-planalto\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bolsonaro veta projeto que facilitaria acesso a rem\u00e9dios orais contra c\u00e2ncer, informa Planalto | FEMAMA\" \/>\n<meta property=\"og:description\" content=\"Projeto visava reduzir exig&ecirc;ncias relacionadas aos planos de sa&uacute;de. Segundo governo, texto poderia comprometer o mercado por n&atilde;o observar aspectos como &#039;previsibilidade&#039;.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/femama.org.br\/site\/noticias-recentes\/bolsonaro-veta-projeto-que-facilitaria-acesso-a-remedios-orais-contra-cancer-informa-planalto\/\" \/>\n<meta property=\"og:site_name\" content=\"FEMAMA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/femamabrasil\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-27T03:00:00+00:00\" \/>\n<meta name=\"author\" content=\"gabriel\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@femama_\" \/>\n<meta name=\"twitter:site\" content=\"@femama_\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"gabriel\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/bolsonaro-veta-projeto-que-facilitaria-acesso-a-remedios-orais-contra-cancer-informa-planalto\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/bolsonaro-veta-projeto-que-facilitaria-acesso-a-remedios-orais-contra-cancer-informa-planalto\\\/\"},\"author\":{\"name\":\"gabriel\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#\\\/schema\\\/person\\\/b29142fa397d7b6b81efc40a77b11cc8\"},\"headline\":\"Bolsonaro veta projeto que facilitaria acesso a rem\u00e9dios orais contra c\u00e2ncer, informa Planalto\",\"datePublished\":\"2021-07-27T03:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/bolsonaro-veta-projeto-que-facilitaria-acesso-a-remedios-orais-contra-cancer-informa-planalto\\\/\"},\"wordCount\":748,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#organization\"},\"articleSection\":[\"Direito dos Pacientes\",\"Not\u00edcias recentes\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/bolsonaro-veta-projeto-que-facilitaria-acesso-a-remedios-orais-contra-cancer-informa-planalto\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/bolsonaro-veta-projeto-que-facilitaria-acesso-a-remedios-orais-contra-cancer-informa-planalto\\\/\",\"url\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/bolsonaro-veta-projeto-que-facilitaria-acesso-a-remedios-orais-contra-cancer-informa-planalto\\\/\",\"name\":\"Bolsonaro veta projeto que facilitaria acesso a rem\u00e9dios orais contra c\u00e2ncer, informa Planalto | FEMAMA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#website\"},\"datePublished\":\"2021-07-27T03:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/bolsonaro-veta-projeto-que-facilitaria-acesso-a-remedios-orais-contra-cancer-informa-planalto\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/bolsonaro-veta-projeto-que-facilitaria-acesso-a-remedios-orais-contra-cancer-informa-planalto\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/bolsonaro-veta-projeto-que-facilitaria-acesso-a-remedios-orais-contra-cancer-informa-planalto\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/femama.org.br\\\/site\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bolsonaro veta projeto que facilitaria acesso a rem\u00e9dios orais contra c\u00e2ncer, informa Planalto\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#website\",\"url\":\"https:\\\/\\\/femama.org.br\\\/site\\\/\",\"name\":\"FEMAMA\",\"description\":\"Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama\",\"publisher\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/femama.org.br\\\/site\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#organization\",\"name\":\"Femama | Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama\",\"url\":\"https:\\\/\\\/femama.org.br\\\/site\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/logotipo-femama-horizontal.png\",\"contentUrl\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/logotipo-femama-horizontal.png\",\"width\":300,\"height\":92,\"caption\":\"Femama | Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama\"},\"image\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/femamabrasil\",\"https:\\\/\\\/x.com\\\/femama_\",\"https:\\\/\\\/www.instagram.com\\\/femama.brasil\\\/\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/femamaorg\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#\\\/schema\\\/person\\\/b29142fa397d7b6b81efc40a77b11cc8\",\"name\":\"gabriel\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e4c92f9be1169f04ec9350f2fbdf2115001e1c34eff29c7df9aea9b4eb22a84e?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e4c92f9be1169f04ec9350f2fbdf2115001e1c34eff29c7df9aea9b4eb22a84e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e4c92f9be1169f04ec9350f2fbdf2115001e1c34eff29c7df9aea9b4eb22a84e?s=96&d=mm&r=g\",\"caption\":\"gabriel\"},\"sameAs\":[\"https:\\\/\\\/gabrielpiziolo.com.br\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bolsonaro veta projeto que facilitaria acesso a rem\u00e9dios orais contra c\u00e2ncer, informa Planalto | FEMAMA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/femama.org.br\/site\/noticias-recentes\/bolsonaro-veta-projeto-que-facilitaria-acesso-a-remedios-orais-contra-cancer-informa-planalto\/","og_locale":"pt_BR","og_type":"article","og_title":"Bolsonaro veta projeto que facilitaria acesso a rem\u00e9dios orais contra c\u00e2ncer, informa Planalto | FEMAMA","og_description":"Projeto visava reduzir exig&ecirc;ncias relacionadas aos planos de sa&uacute;de. Segundo governo, texto poderia comprometer o mercado por n&atilde;o observar aspectos como 'previsibilidade'.","og_url":"https:\/\/femama.org.br\/site\/noticias-recentes\/bolsonaro-veta-projeto-que-facilitaria-acesso-a-remedios-orais-contra-cancer-informa-planalto\/","og_site_name":"FEMAMA","article_publisher":"https:\/\/www.facebook.com\/femamabrasil","article_published_time":"2021-07-27T03:00:00+00:00","author":"gabriel","twitter_card":"summary_large_image","twitter_creator":"@femama_","twitter_site":"@femama_","twitter_misc":{"Escrito por":"gabriel","Est. tempo de leitura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/bolsonaro-veta-projeto-que-facilitaria-acesso-a-remedios-orais-contra-cancer-informa-planalto\/#article","isPartOf":{"@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/bolsonaro-veta-projeto-que-facilitaria-acesso-a-remedios-orais-contra-cancer-informa-planalto\/"},"author":{"name":"gabriel","@id":"https:\/\/femama.org.br\/site\/#\/schema\/person\/b29142fa397d7b6b81efc40a77b11cc8"},"headline":"Bolsonaro veta projeto que facilitaria acesso a rem\u00e9dios orais contra c\u00e2ncer, informa Planalto","datePublished":"2021-07-27T03:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/bolsonaro-veta-projeto-que-facilitaria-acesso-a-remedios-orais-contra-cancer-informa-planalto\/"},"wordCount":748,"commentCount":0,"publisher":{"@id":"https:\/\/femama.org.br\/site\/#organization"},"articleSection":["Direito dos Pacientes","Not\u00edcias recentes"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/femama.org.br\/site\/noticias-recentes\/bolsonaro-veta-projeto-que-facilitaria-acesso-a-remedios-orais-contra-cancer-informa-planalto\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/bolsonaro-veta-projeto-que-facilitaria-acesso-a-remedios-orais-contra-cancer-informa-planalto\/","url":"https:\/\/femama.org.br\/site\/noticias-recentes\/bolsonaro-veta-projeto-que-facilitaria-acesso-a-remedios-orais-contra-cancer-informa-planalto\/","name":"Bolsonaro veta projeto que facilitaria acesso a rem\u00e9dios orais contra c\u00e2ncer, informa Planalto | FEMAMA","isPartOf":{"@id":"https:\/\/femama.org.br\/site\/#website"},"datePublished":"2021-07-27T03:00:00+00:00","breadcrumb":{"@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/bolsonaro-veta-projeto-que-facilitaria-acesso-a-remedios-orais-contra-cancer-informa-planalto\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/femama.org.br\/site\/noticias-recentes\/bolsonaro-veta-projeto-que-facilitaria-acesso-a-remedios-orais-contra-cancer-informa-planalto\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/bolsonaro-veta-projeto-que-facilitaria-acesso-a-remedios-orais-contra-cancer-informa-planalto\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/femama.org.br\/site\/"},{"@type":"ListItem","position":2,"name":"Bolsonaro veta projeto que facilitaria acesso a rem\u00e9dios orais contra c\u00e2ncer, informa Planalto"}]},{"@type":"WebSite","@id":"https:\/\/femama.org.br\/site\/#website","url":"https:\/\/femama.org.br\/site\/","name":"FEMAMA","description":"Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama","publisher":{"@id":"https:\/\/femama.org.br\/site\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/femama.org.br\/site\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/femama.org.br\/site\/#organization","name":"Femama | Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama","url":"https:\/\/femama.org.br\/site\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/femama.org.br\/site\/#\/schema\/logo\/image\/","url":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2021\/12\/logotipo-femama-horizontal.png","contentUrl":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2021\/12\/logotipo-femama-horizontal.png","width":300,"height":92,"caption":"Femama | Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama"},"image":{"@id":"https:\/\/femama.org.br\/site\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/femamabrasil","https:\/\/x.com\/femama_","https:\/\/www.instagram.com\/femama.brasil\/","https:\/\/www.youtube.com\/user\/femamaorg"]},{"@type":"Person","@id":"https:\/\/femama.org.br\/site\/#\/schema\/person\/b29142fa397d7b6b81efc40a77b11cc8","name":"gabriel","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/e4c92f9be1169f04ec9350f2fbdf2115001e1c34eff29c7df9aea9b4eb22a84e?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e4c92f9be1169f04ec9350f2fbdf2115001e1c34eff29c7df9aea9b4eb22a84e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e4c92f9be1169f04ec9350f2fbdf2115001e1c34eff29c7df9aea9b4eb22a84e?s=96&d=mm&r=g","caption":"gabriel"},"sameAs":["https:\/\/gabrielpiziolo.com.br"]}]}},"_links":{"self":[{"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/posts\/19712","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/comments?post=19712"}],"version-history":[{"count":0,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/posts\/19712\/revisions"}],"wp:attachment":[{"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/media?parent=19712"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/categories?post=19712"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/tags?post=19712"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}